Bioventix PLC (LON:BVXP)‘s stock had its “corporate” rating restated by investment analysts at FinnCap in a research note issued on Tuesday. They presently have a GBX 1,450 ($17.99) price target on the biotechnology company’s stock. FinnCap’s target price suggests a potential upside of 9.19% from the stock’s previous close.
Bioventix PLC (LON:BVXP) opened at 1328.00 on Tuesday. The stock’s 50 day moving average price is GBX 1,385.40 and its 200-day moving average price is GBX 1,121.62. The stock’s market capitalization is GBX 67.06 million. Bioventix PLC has a 12-month low of GBX 899.50 and a 12-month high of GBX 1,600.00.
The firm also recently announced a dividend, which was paid on Friday, November 11th. Investors of record on Thursday, October 27th were paid a GBX 46 ($0.57) dividend. This is a positive change from Bioventix PLC’s previous dividend of $16.50. This represents a yield of 3.15%. The ex-dividend date of this dividend was Thursday, October 27th.
In related news, insider Ian James Nicholson sold 2,000 shares of the company’s stock in a transaction on Friday, November 18th. The stock was sold at an average price of GBX 1,300 ($16.13), for a total value of £26,000 ($32,254.06).